Former FDA commissioner Dr. Scott Gottlieb said inoculations "should be a backstop" against a new coronavirus variant initially found in the United Kingdom that has now been detected in the United..
While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.